Qbiotics address this with an announcement yesterday ( 13th Oct )
'QBiotics also notes that our company has a strong intellectual property position around this class of molecule being the holder of a number of patent families covering tigilanol tiglate, related analogues and their use in multiple therapeutic indications.
Overall, although interesting, this academic work has no impact on our commercial position or plans with tigilanol tiglate.'
hope our patent is water tight!
cheers PC
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics address this with an announcement yesterday ( 13th Oct...
- There are more pages in this discussion • 267 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)